Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Italy / NCT07805668
Recruiting Observational

Emotional Dysregulation and Other Psychopathological Dimensions in Clinical Preschoolers

NCT07805668 · tracked via the Priya Life Science Italy tracker
Sponsor
IRCCS Fondazione Stella Maris
Phase
Observational
Started
2025-10-14
Last updated
2026-09-04

Condition(s) studied

Behavioral and Emotional Disorder With Onset in Childhood

Study summary

The purpose of the study is to investigate the emotional-behavioral dysregulation and its possible correlation with the main demographic and psychopathological variables in a sample of preschool children with internalizing and externalizing disorders.

Eligibility

Sex
ALL
Min age
3 Years
Max age
6 Years
Healthy volunteers
No
Inclusion Criteria: Inclusion criteria: * Age between 3 and 6 years * Presence of an internalizing and/or externalizing disorder * Parent completion of the questionnaires * Parent/caregiver signed informed consent for participation in the study Exclusion criteria: * Age greater than 6 years

Primary outcome measure(s)

  • EDI-YC (Emotional Dysregulation Inventory-Young Child) — Baseline
    EDI-YC is a questionnaire developed to assess emotional dysregulation (ED) in children aged 2 to 5 years, both with and without neuropsychological disabilities. Parents are asked to rate their children's emotional behaviors by assigning a score reflecting the frequency and intensity of emotional dysregulation manifestations (0 = not at all; 4 = very serious).

Trial sites (1)

FacilityCityRegionStatus
IRCCS Stella Maris Pisa Italy Recruiting

More IRCCS Fondazione Stella Maris trials in Italy

PACE Study: School-Based Mindfulness and Compassion Interventions for Children Recruiting
Validation of AI for Personalized Assessment and Rehabilitation of Upper Limb in Children With Unilateral Cerebral Palsy Starting soon
SOCIAL: Adaptation and Validation of the In-person PEERS® Program for Adolescents With Autism. Starting soon
7T Anatomo-functional Characterization of Structures in the Action Observation Network Recruiting
Genetic and Clinical Correlates of Disruptive Behavior Disorder With and Without Callous-Unemotional Traits Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07805668 on ClinicalTrials.gov ↗ ← All trials in Italy